hims fda warning letter compounded semaglutide 2025 The announced plans to take action against non-FDA-approved GLP-1 receptor agonists, a move that prompted telehealth company & Hers to yank its new (Wegovy) weight-loss pill from the Compounded "semaglutide" is not FDA-approved

These celebrities have dropped quite a few pounds in 2024, and their fans just can't believe it was all natural in the age of Ozempic

Acid suppression Proton pump inhibitors (PPIs): omeprazole, pantoprazole H2 receptor blockers: ranitidine, famotidine 3

Policy and Global Health Policy advances in 2025 laid critical groundwork for the next phase of obesity care

Fella Health reviewed: provider credentialing, pharmacy sourcing, clinical oversight, and program transparency

Nestl is rolling out Vital, a nutrient-dense protein shake line aimed at aging consumers and the GLP-1 era.

drug redirecting drug respositioning (drug repositioning) , ..